Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local relapse patterns after preoperative radiotherapy of limb and trunk wall soft tissue sarcomas: Prognostic role of imaging and pathologic response factors.

Clinical and translational radiation oncology·2024
Same author

Treatment of presumed aseptic non-union of the humeral shaft by osteosynthesis combining intramedullary nailing and screw plate.

Acta orthopaedica Belgica·2024
Same author

Bariatric surgery: Have we reached the age of maturity?

Journal of visceral surgery·2023
Same author

Anal incontinence incidence is high in patients with obesity prior to bariatric surgery: Prevalence, risks-factors.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

Beyond green surgery, green surgical innovation and research.

Journal of visceral surgery·2022
Same author

Robotic trans-abdominal preperitoneal patch pasty (re-TAPP) hernia repair (with video).

Journal of visceral surgery·2022

Related Experiment Video

Updated: Jul 7, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Bone metastases from differentiated thyroid carcinoma.

M M Muresan1, P Olivier, J Leclère

  • 1Endocrinology Department and Nuclear Medicine Department, Hôpital Brabois Adultes, CHU Nancy, Vandoeuvre, France. m.muresan@chr-metz-thionville.fr

Endocrine-Related Cancer
|March 4, 2008
PubMed
Summary
This summary is machine-generated.

Distant metastases from differentiated thyroid cancer significantly reduce survival. Bone metastases cause severe pain and complications, necessitating advanced imaging and multimodal treatment strategies for improved patient outcomes.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Related Experiment Videos

Last Updated: Jul 7, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Area of Science:

  • Oncology
  • Radiology
  • Nuclear Medicine

Background:

  • Distant metastases from differentiated thyroid carcinoma (DTC) reduce 10-year survival by 50%.
  • Bone metastases are a frequent complication of follicular thyroid cancer, severely impacting quality of life.
  • Diagnosis relies on correlating clinical suspicion with advanced imaging techniques.

Purpose of the Study:

  • To review the diagnostic and therapeutic strategies for bone metastases in differentiated thyroid cancer.
  • To highlight the role of advanced imaging in detecting and assessing skeletal lesions.
  • To discuss current and emerging treatment modalities for managing bone metastases.

Main Methods:

  • Review of current literature on differentiated thyroid cancer bone metastases.
  • Discussion of diagnostic imaging modalities including MRI and PET/CT.
  • Evaluation of therapeutic approaches such as radioiodine, bisphosphonates, and surgical interventions.

Main Results:

  • Advanced imaging like skeletal MRI and (18F)FDG-PET/CT are crucial for diagnosis and staging.
  • Novel imaging like (124)I-PET/CT aids in evaluating well-differentiated lesions.
  • Bisphosphonates, radioiodine, and multimodal approaches improve complication rates and pain management.

Conclusions:

  • Effective management of DTC bone metastases requires a multimodal approach integrating advanced imaging and targeted therapies.
  • Minimally invasive techniques and patient selection are key for optimal surgical outcomes.
  • Ongoing research into tumor-bone microenvironment interactions may yield novel therapeutic targets for less differentiated tumors.